Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecci among cystic fibrosis patients in Spain

Clinical Microbiology and Infection

Volumn 11, Issue 12, 2005, Pages 1012-1015

  Respaldiza, N ^a   Montes Cano, M A ^a   Dapena, F J ^a   de la Horra, C ^a   Mateos, I ^a   Medrano, F J ^a   Calderon, E ^a   Varela, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Colonisation; Cystic fibrosis; Genotypes; Pneumocystis jirovecii; Pneumonia

Indexed keywords

AZITHROMYCIN; FUNGAL RNA; LARGE SUBUNIT RIBOSOMAL RNA;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CYSTIC FIBROSIS; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; FUNGAL COLONIZATION; FUNGAL GENETICS; FUNGUS IDENTIFICATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEQUENCE ANALYSIS; SPAIN; SPUTUM ANALYSIS; STATISTICAL ANALYSIS;

FUNGI; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 28644438823     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01276.x     Document Type: Article

References (25)

1. Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet 1998; 351: 277-282.
2. Sing A, Geiger AM, Hogardt M et al. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. J Clin Microbiol 2001; 39: 2717-2718.
3. Bech B, Pressler T, Iversen M et al. Long-term outcome of lung transplantation for cystic fibrosis - Danish results. Eur J Cardiothorac Surg 2004; 26: 1180-1186.
4. Stringer JR, Beard CB, Miller RF et al. A new name (Pneumocystis jiroveci) for pneumocystis from humans. Emerg Infect Dis 2002; 8: 891-896.
5. Miller R, Huang L. Pneumocystis jirovecii infection. Thorax 2004; 59: 731-733.
6. Varthalitis I, Aoun M, Daneau D et al. Pneumocystis carinii pneumonia in patients with cancer: an increasing incidence. Cancer 1993; 71: 481-485.
7. Cardenal R, Medrano FJ, Varela JM et al. Pneumocystis pneumonia in heart transplant recipients. Eur J Cardiothorac Surg 2001; 20: 799-802.
8. Calderon EJ, Regordan C, Medrano FJ et al. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet 1996; 34: 977.
9. Medrano FJ, Respaldiza N, Medrano A et al. Seroprevalence of Pneumocystis human infection in Southern Spain. J Eukaryot Microbiol 2003; 50: 649-650.
10. Respaldiza N, Medrano FJ, Medrano AC et al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect 2004; 10: 1029-1031.
11. Varela JM, Dapena J, Regordan C et al. Absence of Pneumocystis carinii carriers among patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 1998; 17: 741-742.
12. Royce FH, Blumberg DA. Pneumocystis carinii isolated from lung lavage fluid in an infant with cystic fibrosis. Pediatric Pulmonol 2000; 29: 235-238.
13. Varela JM, Respaldiza N, Sánchez B et al. Lymphocyte response in subjects with chronic pulmonary diseases colonized by Pneumocystis jirovecii. J Eukaryot Microbiol 2003; 50: 672-673.
14. Montes-Cano MA, de la Horra C, Martín-Juan J et al. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 2004; 39: 123-128.
15. Calderon E, de la Horra C, Medrano FJ et al. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis 2004; 23: 545-549.
16. Sing A, Roggenkamp A, Autenrieth IB et al. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol 1999; 37: 3409-3410.
17. Fischer S, Wee JG, Kovacs J et al. The use of oral washes to diagnose Pneumocystis carinii pneumonia: a blinded prospective study using polymerase chain reaction-based detection system. J Infect Dis 2001; 184: 1485-1488.
18. Totet A, Respaldiza N, Pautard JC et al. Pneumocystis jiroveci genotypes and primary infection. Clin Infect Dis 2003; 36: 1340-1342.
19. Dumoulin A, Mazars E, Seguy N et al. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected host to susceptible hosts. Eur J Clin Microbiol Infect Dis 2000; 19: 671-678.
20. Vargas SL, Ponce CA, Giglotti F et al. Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol 2000; 38: 1536-1538.
21. Miller RF, Ambrose HE, Wakefield AE. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J Clin Microbiol 2001; 39: 3877-3882.
22. Halme M, Lautenschlager I, Mattila S et al. Breakthrough Pneumocystis carinii infections in lung and heart-lung transplant patients with chemoprophylaxis. Transplant Proc 1999; 31: 197.
23. Peckham DG. Macrolide antibiotics and cystic fibrosis. Thorax 2002; 57: 189-190.
24. Dunne MW, Bozzette S, McCutchan JA et al. Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California collaborative trust Group. Lancet 1999; 354: 891-895.
25. Miller RF. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing? Thorax 2000; 55: S15-22.